钠-葡萄糖共转运蛋白2抑制剂的临床安全性：基于北京地区2019—2024年药品不良反应监测数据的研究
解玥, 宋智慧, 刘俊含, 赵慧颖, 张国娟, 王家伟
Clinical safety of sodium-glucose cotransporter 2 inhibitors: a study based on adverse drug reaction monitoring data in Beijing from 2019 to 2024
Xie Yue, Song Zhihui, Liu Junhan, Zhao Huiying, Zhang Guojuan, Wang Jiawei
药物不良反应杂志 . 2025, (11): 660 -666 .  DOI: 10.3760/cma.j.cn114015-20250108-00019